Chemical and Biological Agent Deny: Selective Phosphate Ester Hydrolysis

Award Information
Agency:
Department of Defense
Branch
Defense Threat Reduction Agency
Amount:
$99,985.00
Award Year:
2006
Program:
SBIR
Phase:
Phase I
Contract:
HDTRA1-06-P-0114
Agency Tracking Number:
RDI060003702
Solicitation Year:
2006
Solicitation Topic Code:
DTRA06-012
Solicitation Number:
2006.1
Small Business Information
CALDERA PHARMACEUTICALS, INC.
903 Tewa Loop, Los Alamos, NM, 87544
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
147452275
Principal Investigator:
Michael Harris
Senior Biologist
(505) 379-2735
harris@caldera-pharmaceuticals.com
Business Contact:
Benjamin Warner
CEO/CSO
(505) 412-2345
warner@caldera-pharmaceuticals.com
Research Institution:
n/a
Abstract
This proposed work will generate a targeted phosphate ester hydrolysis catalyst for agent denial. This catalyst will be targeted by conjugation to single stranded DNA. Characteristics of the catalyst will be determined, including ruggedness, targeting selectivity, and potential methods for deployment.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government